Neotropix, Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Neotropix, Inc.
Novartis's dispersible ACT treatment set to improve malaria treatment in children
A new formulation of the malaria treatment Coartem designed specifically for children has been developed and launched by Novartisand the Medicines for Malaria Venture(MMV).
Start-Up Previews (5/05)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, New Approaches to Heart Valve Repair and Replacement, features profiles of 3F Therapeutics, Arbor Surgical Technologies and Heart Leaflet Technologies. Plus these Start-Ups Across Health Care: Neotropix, NeuroHealing Pharmaceuticals, Othera Pharmaceuticals and Vitra Bioscience.
Neotropix Inc.
Neotropix Inc. believes it is on the right track to develop a virus that just infects cancer cells, at least for cancers with specific neuroendocrine properties -- a feat that would amount to the mythic "silver bullet" cancer cure.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice